Physician access to drug profiles to reduce adverse reactions

William A. Yasnoff, Edward L. Tomkins, Louise M. Dunn

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Adverse drug reactions (ADRs) are a major source of preventable morbidity and mortality, especially among the elderly, who use more drugs and are more sensitive to them. The insurance industry has recently addressed this problem through the implementation of drug interaction alerts to pharmacists in conjunction with immediate online claims adjudication for almost 60% of prescriptions (expected to reach 90% within 5 years). These alerts are based on stored patient drug profiles maintained by pharmacy benefit managers (PBMs) which are updated whenever prescriptions are filled. While these alerts are very helpful, the pharmacist does not prescribe, resulting in time-consuming and costly delays to contact the physician and remedy potential interactions. We have developed and demonstrated the feasibility of the PINPOINT (Pharmaceutical Information Network for prevention of interactions) system for making the drug profile and interaction information easily available to the physician before the prescription is written. We plan to test the cost-effectiveness of the system in a prospective controlled clinical trial.

Original languageEnglish (US)
Title of host publicationProceedings of SPIE - The International Society for Optical Engineering
EditorsWarren S. Grundfest
Pages121-130
Number of pages10
Volume2499
StatePublished - 1995
Externally publishedYes
EventHealth Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions - Arlington, VA, USA
Duration: May 10 1995May 12 1995

Other

OtherHealth Care Technology Policy II: The Role of Technology in the Cost of Health Care: Providing the Solutions
CityArlington, VA, USA
Period5/10/955/12/95

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Condensed Matter Physics

Fingerprint

Dive into the research topics of 'Physician access to drug profiles to reduce adverse reactions'. Together they form a unique fingerprint.

Cite this